Cost-effectiveness analysis of endometrial cancer prevention strategies for obese women

Obstetrics and Gynecology

Volumn 112, Issue 1, 2008, Pages 56-63

  Kwon, Janice S ^a   Lu, Karen H ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; AGED; ANOVULATION; ARTICLE; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; FEMALE; HIGH RISK POPULATION; HUMAN; HYPOTHESIS; LIFE EXPECTANCY; MEDICAL DECISION MAKING; MORBID OBESITY; OBESITY; OUTCOME ASSESSMENT; POPULATION RISK; PRIORITY JOURNAL; PROBABILITY; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; TREATMENT DURATION; UNITED STATES; BIOPSY; COST BENEFIT ANALYSIS; ECONOMICS; ENDOMETRIUM; ENDOMETRIUM TUMOR; MASS SCREENING; METHODOLOGY; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; BIOPSY; CONTRACEPTIVES, ORAL, HORMONAL; COST-BENEFIT ANALYSIS; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; MARKOV CHAINS; MASS SCREENING; MIDDLE AGED; OBESITY;

EID: 48549098558     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e31817d53a4     Document Type: Article

References (67)

1. National Cancer Institute, Surveillance Epidemiology and End Results. Cancer of the Corpus and Uterus, NOS. Available at: http://seer.cancer.gov/ statfacts/html/corp.html?statfacts-page= corp. Retrieved March 2, 2008.
2. Polednak AP. Trends in incidence rates for obesity-associated cancers in the US. Cancer Detect Prev 2003;27:415-21.
3. Brinton LA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, et al. Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study. Am J Obstet Gynecol 1992;167:1317-25.
4. Chang SC, Lacey JV Jr, Brinton LA, Hartge P, Adams K, Mouw T, et al. Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study. Cancer Epidemiol Biomarkers Prev 2007;16:723-30.
5. Friberg E, Mantzoros CS, Wolk A. Diabetes and risk of endometrial cancer: a population-based prospective cohort study. Cancer Epidemiol Biomarkers Prev 2007;16:276-80.
6. Friedenreich C, Cust A, Lahmann PH, Steindorf K, Boutron-Ruault MC, Clavel-Chapelon F, et al. Anthropometric factors and risk of endometrial cancer: the European prospective investigation into cancer and nutrition. Cancer Causes Control 2007;18:399-413.
7. Parslov M, Lidegaard O, Klintorp S, Pedersen B,Jonsson L, Eriksen PS, et al. Risk factors among young women with endometrial cancer: a Danish case-control study. Am J Obstet Gynecol 2000;182:23-9.
8. Salazar-Martinez E, Lazcano-Ponce EC, Lira-Lira GG, Escudero-De los Rios P, Salmeron-Castro J, Larrea F, et al. Case-control study of diabetes, obesity, physical activity and risk of endometrial cancer among Mexican women. Cancer Causes Control 2000;11:707-11.
9. Schouten LJ, Goldbohm RA, van den Brandt PA. Anthropometry, physical activity, and endometrial cancer risk: results from the Netherlands Cohort Study. J Natl Cancer Inst 2004; 96:1635-8.
10. Stanford JL, Brinton LA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, et al. Oral contraceptives and endometrial cancer: do other risk factors modify the association? Intl J Cancer 1993;54:243-8.
11. Trentham-Dietz A, Nichols HB, Hampton JM, Newcomb PA. Weight change and risk of endometrial cancer. Int J Epidemiol 2006;35:151-8.
12. Tao MH, Xu WH, Zheng W, Zhang ZF, Gao YT, Ruan ZX, et al. Oral contraceptive and IUD use and endometrial cancer: a population-based case-control study in Shanghai, China. Int J Cancer 2006;119:2142-7.
13. Vessey M, Painter R. Oral contraceptive use and cancer. Findings in a large cohort study, 1968-2004. Br J Cancer 2006;95:385-9.
14. Weiderpass E, Adami HO, Baron JA, Magnusson C, Lindgren A, Persson I. Use of oral contraceptives and endometrial cancer risk (Sweden). Cancer Causes Control 1999;10:277-84.
15. Combination oral contraceptive use and the risk of endometrial cancer. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development. JAMA 1987;257:796-800.
16. Levi F, La Vecchia C, Gulie C, Negri E, Monnier V, Franceschi S, et al. Oral contraceptives and the risk of endometrial cancer. Cancer Causes Control 1991;2:99-103.
17. Lindor NM, Petersen GM, Hadley DW, Kinney AY, Miesfeldt S, Lu KH, et al. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA 2006;296:1507-17.
18. Vasen HF, Moslein G, Alonso A, Bernstein I, Bertario L, Blanco I, et al. Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet 2007;44:353-62.
19. Hirth RA, Chernew ME, Miller E, Fendrick AM, Weissert WG Willingness to pay for a quality-adjusted life year: in search of a standard. Med Decis Making 2000;20:332-42.
20. Weinstein MC, SiegelJE, Gold MR, Kamlet MS, Russell LB. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA 1996;276:1253-8.
21. National Cancer Institute, Surveillance Epidemiology and End Results. SEER cancer statistics review. Cancer of the corpus and uterus, NOS. SEER incidence and U.S. death rates, age-adjusted and age-specific rates, by race, 2000-2004. Available at: http://seer.cancer.gov/csr/1975-2004/results-single/ sect-07-table.04.pdf. Retrieved November 26, 2007.
22. Myriam Hunink MG, Glasziou PP. Decision making in health and medicine: integrating evidence and values. Cambridge (UK): Cambridge University Press; 2001.
23. Chan WS, Ray J, Wai EK, Ginsburg S, Hannah ME, Corey PN, et al. Risk of stroke in women exposed to low-dose oral contraceptives: a critical evaluation of the evidence [published erratum appears in Arch Intern Med 2005; 165:2040]. Arch Intern Med 2004;164:741-7.
24. Farley TM, Meirik O, Chang CL, Poulter NR Combined oral contraceptives, smoking, and cardiovascular risk. J Epidemiol Community Health 1998;52:775-85.
25. Farmer RD, Lawrenson RA, Thompson CR, Kennedy JG, Hambleton IR. Population-based study of risk of venous thromboembolism associated with various oral contraceptives. Lancet 1997;349:83-8.
26. Gillum LA, Mamidipudi SK,Johnston SC. Ischemic stroke risk with oral contraceptives: a meta-analysis. JAMA 2000;284: 72-8.
27. Jick H, KayeJA, Vasilakis-Scaramozzajick SS. Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysis. BMJ 2000;321:1190-5.
28. Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet 1997;349:1202-9.
29. Pirog EC, Heller DS, Westhoff C. Endometrial adenocarcinoma - lack of correlation between treatment delay and tumor stage. Gynecol Oncol 1997;67:303-8.
30. Berek JS, Hacker NF, editors. Practical gynecologic oncology. 2nd ed. Baltimore (MD): Williams & Wilkins; 1994.
31. Dijkhuizen FP, Mol BW, Brolmann HA, Heintz AP. The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta-analysis. Cancer 2000;89:1765-72.
32. Folger SG, Marchbanks PA, McDonald JA, Bernstein L, Ursin G, Berlin JA, et al. Risk of breast cancer associated with short-term use of oral contraceptives. Cancer Causes Control 2007;18:189-98.
33. Milne RL, Knight JA John EM, Dite GS, Balbuena R, Ziogas A, et al. Oral contraceptive use and risk of early-onset breast cancer in carriers and noncarriers of BRCA1 and BRCA2 mutations. Cancer Epidemiol Biomarkers Prev 2005;14:350-6.
34. Wingo PA, Austin H, Marchbanks PA, Whiteman MK, HsiaJ, Mandel MG, et al. Oral contraceptives and the risk of death from breast cancer [published erratum appears in Obstet Gynecol 2008;111:454]. Obstet Gynecol 2007;110:793-800.
35. U.S. Department of Health and Human Services, Centers for Medicare and Medicaid Services. Physician fee schedule overview. 2008. Available at: http://ww.cms.hhs.gov/ PhysicianFeeSched/01-overview.asp. Retrieved November 26, 2007.
36. Hospital and Ambulatory Surgery Care for Women's Cancers: HCUP Highlight, Issue 2. AHRQ Publication No. 06-0038, September 2006. Rockville (MD): Agency for Healthcare Research and Quality; 2006. Available at: http://www.ahrq. gov/data/hcup/highlight2/high2.htm. Retrieved November 26, 2007.
37. Merrill CT, Elixhauser E. Hospitalization in the United States, 2002. AHRQ, Publication No. 05-0056, June 2005. Rockville (MD): Agency for Healthcare Research and Quality; 2005. Available at: http://www.ahrq.gov/data/hcup/factbk6/ factbk6d. htm. Retrieved November 26, 2007.
38. Red Book 2006: Pharmacy's Fundamental Reference. 110th ed. Montvale (NJ): Thomson Healthcare; 2006.
39. National Compensation Survey: Occupational Wages in the United States, June 2006. Summary 07-03. U.S. Department of Labor, U.S. Bureau of Labor Statistics, June 2007. Available at: http://www.bls.gov/ncs/ocs/sp/ncbl0910.pdf. Retrieved November 26, 2007.
40. A Primer on Gasoline Prices. Energy Information Administration, DOE/EIA-X040, May 2006. Available at: http://www. eia.doe.gov/bookshelf/ brochures/gasolinepricesprimer/ printerversion.pdf. Retrieved May 19, 2008.
41. Relative survival rates by survival time: Corpus and Uterus, NOS. Surveillance Epidemiology and End Results, U.S. National Institutes of Health, 1988-2004. Available at: http:// seer.cancer.gOv/faststats/selections. php#Output. Retrieved May 19, 2008.
42. Bateman BT, Schumacher HC, Boden-Albala B, Berman MF, Mohr JP, Sacco RL, et al. Factors associated with in-hospital mortality after administration of thrombolysis in acute ischemic stroke patients: an analysis of the nationwide inpatient sample 1999 to 2002 [published erratum appears in Stroke 2007;38:451]. Stroke 2006;37:440-6.
43. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR Kottke TE, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med 2007;356:2388-98.
44. Poulter NR. Risk of fatal pulmonary embolism with oral contraceptives. Lancet 2000;355:2088.
45. Flegal KM, Graubard BI, Williamson DF, Gail MH. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA 2007;298:2028-37.
46. Raebel MA, Malone DC, Conner DA, Xu S, Porter JA, Lanty FA. Health services use and health care costs of obese and nonobese individuals. Arch Intern Med 2004;164:2135-40.
47. Franz MJ. Effectiveness of weight loss and maintenance interventions in women. Curr Diab Rep 2004;4:387-93.
48. Heshka S, Anderson JW, Atkinson RL, Greenway FL, Hill JO, Phinney SD, et al. Weight loss with self-help compared with a structured commercial program: a randomized trial. JAMA 2003;289:1792-8.
49. McTigue KM, Hess R, Ziouras J. Obesity in older adults: a systematic review of the evidence for diagnosis and treatment. Obesity (Silver Spring) 2006;14:1485-97.
50. Mann T, Tomiyama AJ, Westling E, Lew AM, Samuels B, ChatmanJ. Medicare's search for effective obesity treatments: diets are not the answer. Am Psychol 2007;62:220-33.
51. Anderson KJacobsonJS, Heitjan DF, ZivinJG, Hershman D, Neugut Al, et al. Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation. Ann Intern Med 2006;144:397-406.
52. Goldie SJ, Kohli M, Grima D, Weinstein MC, Wright TC, Bosch FX, et al. Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. J Natl Cancer Inst 2004;96:604-15.
53. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348: 1625-38.
54. Montz FJ, Bristow RE, Bovicelli A, Tomacruz R, Kurman RJ. Intrauterine progesterone treatment of early endometrial cancer. Am J Obstet Gynecol 2002;186:651-7.
55. Lord JM, Flight IH, Norman RJ. Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiroinositol) for polycystic ovary syndrome. Cochrane Database of Systematic Reviews 2003, Issue 3. Art. No.: CD003053. DOI: 10.1002/14651858.CD003053.
56. Costello M, Shrestha B, Eden J, Sjoblom P, Johnson N. Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome. Cochrane Database of Systematic Reviews 2007 Issue 1. Art. No.: CD005552. DOI: 10.1002/14651858.CD005552.pub2.
57. Lord JM, Flight IH, Norman RJ. Metformin in polycystic ovary syndrome: systematic review and meta-analysis. BMJ 2003;327:951-3.
58. Bolen S, Feldman L, VassyJ, Wilson L, Yeh HC, Marinopou-los S, et al. Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus. Ann Intern Med 2007;147:386-99.
59. Moysich KB, Baker JA, Rodabaugh KJ, VillellaJA. Regular analgesic use and risk of endometrial cancer. Cancer Epidemiol Biomarkers Prev 2005;14:2923-8.
60. Berger JS, Roncaglioni MC, Avanzini F, Pangrazzi I, Tognoni G, Brown DL. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific metaanalysis of randomized controlled trials [published erratum appears in JAMA 2006;295:2002]. JAMA 2006;295:306-13.
61. Haffner SM. Relationship of metabolic risk factors and development of cardiovascular disease and diabetes. Obesity (Silver Spring) 2006;14:121S-7S.
62. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52.
63. Ayyad C, Andersen T. Long-term efficacy of dietary treatment of obesity: a systematic review of studies published between 1931 and 1999. Obes Rev 2000;1:113-9.
64. Avenell A, Broom J, Brown TJ, Poobalan A, Aucott L, Stearns SC, et al. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. Health Technol Assess 2004;8: 1-182.
65. Rucker D, Padwal R, Li SK, Curioni C, Lau DC. Long term pharmacotherapy for obesity and overweight: updated metaanalysis. BMJ 2007;335:1194-9.
66. Parker ED, Folsom AR. Intentional weight loss and incidence of obesity-related cancers: the Iowa Women's Health Study. IntJ Obes Relat Metab Disord 2003;27:1447-52.
67. National Cancer Institute, Surveillance Epidemiology and End Results. Cancer stat fact sheets. Cancer of the cervix uteri. Available at: http://seer.cancer.gov/statfacts/html/cervix.html? statfacts-page=cervix. html&x=16&y=16. Retrieved March 2, 2008.